Target Healthc. Regulatory News (THRL)

Target Healthcare REIT plc

Completion of new corporate structure and first day of dealings

The Directors of Target Healthcare REIT plc (the "Company") are pleased to announce that the scheme of arrangement in connection with moving the Group's ultimate parent company to a UK domicile has now become unconditional in all respects, and has therefore become effective. The Company, a new English-incorporated company, has been established as the new parent company of Target Healthcare REIT Limited and its group of subsidiaries.

The Company's ordinary shares of £1.00 each (the "Ordinary Shares") have been admitted to the premium segment of the Official List and to trading on the main market of the London Stock Exchange with effect from 8.00 a.m. today.

For information purposes, the trading details in relation to the Company's Ordinary Shares are as follows:

TIDM: THRL

ISIN: GB00BJGTLF51

SEDOL: BJGTLF5

LEI: 213800RXPY9WULUSBC04

Total voting rights

As at 7 August 2019, the Company's issued share capital consists of 385,089,449 Ordinary Shares. The total issued share capital with voting rights is 385,089,449.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Target Fund Managers Limited (Investment Manager to the Company)

Notes:

A copy of this announcement will be available on the Company's website.